Aktis Oncology, Inc. Common stock AKTS
$24.93
+4.79%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-13 | View → |
| 8-K | 8-K | 2026-08-13 | View → |
| 4 | 4 | 2026-07-21 | View → |
| 4 | 4 | 2026-07-20 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 10-Q | 10-Q | 2026-05-11 | View → |
| 8-K | 8-K | 2026-05-11 | View → |
| 4 | 4 | 2026-04-16 | View → |
| 8-K | 8-K | 2026-04-16 | View → |
| 8-K | 8-K | 2026-03-30 | View → |
| 10-K | 10-K | 2026-03-30 | View → |
| 4 | Insider transaction | 2026-01-14 | View → |
| 4 | Insider transaction | 2026-01-14 | View → |
| 4 | Insider transaction | 2026-01-14 | View → |
| 4 | Insider transaction | 2026-01-12 | View → |
| 4 | 4 | 2026-01-12 | View → |
| 4 | 4 | 2026-01-12 | View → |
| 4 | 4 | 2026-01-12 | View → |
| 8-K | 8-K | 2026-01-12 | View → |
| S-1 | S-1 | 2025-12-19 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $24.93
- Market Cap
- $1.33 billion
- 52-Week Range
- $14.72 – $34.19
- Average Volume
- 347K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.